Zymosan is frequently used as an activator of granulocytes to study inflammatory responses. We used zymosan as a model to understand the mechanisms involved in intestinal inflammatory diseases, and our special interest was focused on the smooth muscle function. Moreover, we investigated the role of oxidative stress in intestinal pathology after inflammatory processes. Intraperitoneal injection of zymosan induces a peritoneal inflammation, characterised by exudate in the peritoneum and peritoneal fibrosis. Three days after injection of zymosan (25-40 mg/100 g) we measured a decreased adrenergic smooth muscle response, while the muscarinic receptor-mediated contraction was not significantly affected. Efforts were made to correlate these observations with the development of oxidative stress; however, the intestinal glutathione balance remained undisturbed and no increase in lipid peroxidation products in the intestine was observed. Our conclusion is that peritoneal inflammation will lead to a release of various mediators, which may destroy receptor systems, among which are adrenoceptors. There was no evidence of an important role for reactive oxygen metabolites in this effect.
Several diseases of the gastrointestinal tract are accompanied by the production of reactive oxygen metabolites. Oxygen radicals are supposed to be responsible for gastrointestinal damage after ischaemia and reperfusion. 4 In this process oxygen radicals are produced by two different mechanisms. At first reactive oxygen metabolites can be formed by xanthine oxidase, which metabolises hypoxanthine and xanthine with the use of molecular oxygen as electron acceptor, resulting in production of superoxide anions.' I Secondly, intestinal ischaemia and reperfusion cause an inflammatory response, characterised by infiltration of neutrophils into the ischaemic tissue,7 which also leads to formation of oxygen radicals. It is hypothesised that the infiltrated neutrophils give the major contribution to mucosal injury after intestinal ischaemia and reperfusion.0 Also, in other inflammatory diseases of the intestine oxygen radicals are supposed to contribute to the development of tissue damage.90' Reactive oxygen species also seem to be involved in duodenal ulceration."
Inflammation of the intestine can lead to alterations of intestinal motility,'2-4 but the nature of these alterations is variable. Motility changes are also reported as a consequence of enteric infection.'5 16 Enteric infections can induce inflammatory responses, associated with infiltration of granulocytes into the intestinal mucosa, thereby leading to mucosal injury. '7 In previous studies we investigated the effect of reactive oxygen species on the intestinal smooth muscle in vitro, and we tried to establish the mechanism by which the smooth muscle function is altered. Both hydrogen peroxide and cumene hydroperoxide are capable of reducing smooth muscle responses upon contracting or relaxing agents. The effect on smooth muscle contraction was not clearly elucidated, although the membrane receptor is not likely to be selectively affected by either hydrogen peroxide or cumene hydroperoxide. 18 Lipid peroxidation seems to be responsible for decreased smooth muscle function after oxidative stress in vitro. '9 The ,B adrenergic relaxation of intestinal smooth muscle is also vulnerable to oxidative stress. Moreover, similar to the findings in heart tissue, the effect on the 13 adrenoceptor seems to be more selective. 20"2 In this study we tried to validate the in vitro effects of oxidative stress on intestinal smooth muscle in an inflammation model, and investigated the effect of an inflammatory response on smooth muscle and the possible role of reactive oxygen species in this. To this end we used zymosan as an inducer of in vivo inflammation,22-24 which might affect the intestine. We found that after intraperitoneal injection of zymosan the 13 adrenergic response of the small intestinal smooth muscle was reduced, but no clear evidence was found for the involvement of oxidative stress in this effect. We Myeloperoxidase assay Infiltration of neutrophils into the intestinal mucosa was determined by measurement of tissue associated myeloperoxidase.2' Segments of intestine were homogenised in 10 volumes of 50 mmol/l sodium phosphate buffer (pH 7-4) and centrifuged (20 minutes, 16000 g). The pellet, which contains over 95% of the total tissue myeloperoxidase activity, was resuspended in an equal volume ofpotassium phosphate buffer (pH 6 0) containing 0 5% HTAB as detergent. After another centrifugation step (20 minutes, 16000 g) the supernatant was used for myeloperoxidase assay using TMB. 29 Briefly, aliquots of supernatant were incubated for varying periods with 1-6 mmol/l TMB and 0-3 mmol/l hydrogen peroxide in 80 mmol/l sodium phosphate (pH 5 4) with 60 mmol/l NaCl in a total volume of 500 tl. The reaction was terminated by the addition of 1-75 ml of 200 mmol/l sodium acetate buffer (pH 3-0). The reaction product was measured spectrophotometrically at 655 nm. Activities were expressed as the initial velocity of absorbance increase, which is linear during the first two minutes, at 655 nm (AA655/min) per mg of protein which was measured in the supernatant.
Histological study (Table I ). The maximal relaxation by isoprenaline, which was expressed relatively to the relaxation by 0 5 mmol/l of the stable cAMP analogue dibutyrylcAMP, was also decreased significantly (Table I and Fig 1) .
This might imply that the production of cAMP by stimulation with isoprenaline is decreased. We assessed cAMP production in intestinal membranes by stimulation of the 16 receptor system at various levels -namely, with NaF and forskolin, which stimulate the G- (Fig 2) .
Two parameters of oxidative stress were measured in this study -namely, glutathione levels and lipid peroxidation products. Table III shows that 72 hours of zymosan treatment did not lead to significant alterations in reduced or oxidised glutathione levels. Moreover, no increase was found in TBA-reactive material in the intestine of zymosan treated animals (not shown).
EFFECTS OF ZYMOSAN TREATMENT IN VITRO
From published reports it is known that opsonised zymosan is capable of stimulating the respiratory burst in neutrophils directly. 32 We studied the production of hydrogen peroxide by zymosan and opsonised zymosan in rat intestinal homogenates. Figure 3 shows that opsonised zymosan in contrast to zymosan leads to increased production of hydrogen peroxide in a concentration dependent manner. This implies that only opsonised zymosan stimulates an oxidative burst, whereas non-opsonised zymosan does not.
We studied the in vitro effects of zymosan and opsonised zymosan on isolated intestinal segments. However, at a concentration which stimulates hydrogen peroxide production opsonised zymosan did not affect smooth muscle relaxation by isoprenaline. Both the p(EC50) and the maximal response remained unaffected (Table IV) . The isoprenaline response also was unchanged after incubation with non-opsonised zymosan (Table IV) . Moreover, no evidence could be found for an increased infiltration of neutrophils in the intestinal tissue. Histological study of zymosan treated rat intestine did not show clear modification of intestinal morphology nor infiltration of neutrophils in the intestine. Moreover, no significant increased myeloperoxidase activity was observed in the intestine from rats treated with zymosan, which implies that intraperitoneal injection of zymosan does not induce symptoms like intestinal inflammation, in which infiltration of inflammatory cells is commonly observed and confirmed by increased tissue associated myeloperoxidase activity. 7 28 Since non-inflamed intestinal mucosa also contains neutrophils, we investigated whether these neutrophils upon activation could be responsible for the observed effects on the receptor mediated relaxation. Intestinal homogenates are capable of producing hydrogen peroxide when stimulated with opsonised zymosan. Zymosan which is not opsonised is not capable of stimulating the respiratory burst directly32 and did not induce hydrogen peroxide -production in our system. Although zymosan is not able to induce an oxidative burst in inflammatory cells directly, zymosan injected intraperitoneally might be able to cause indirect oxygen radical production. Interestingly, zymosan has been shown to induce superoxide release in rat Kupffer cells,33 indicating that also non-opsonised zymosan induced release of reactive oxygen species in some systems.
We investigated whether stimulation of the respiratory burst in intestinal neutrophils leads to alterations of the f adrenergic response by treatment of isolated intestinal segments with (opsonised) zymosan, but we found no changes caused by normal zymosan nor by opsonised zymosan in the D adrenergic response. This indicates that radical production induced by opsonised zymosan may be insufficient in our system, or that produced radicals will be scavenged or metabolised before they are able to induce damage to the smooth muscle and the i adrenoceptor system. Moreover, it can be concluded from this that the decreased 3 adrenergic response after intraperitoneal zymosan is not induced by activated mucosal neutrophils, but predominantly by peritoneal macrophages and neutrophils.
Peritoneal macrophages, activated after zymosan injection, may produce a variety of inflammatory mediators and possibly oxygen radicals, which may be responsible for the observed effects in our study. This might be correlated with the effects of in vitro oxidative stress by exogenous application of hydrogen peroxide to the small intestine. In this case the adrenergic response to isoprenaline was also decreased compared with the maximal response to dibutyryl-cAMP.21 Since no proof was found for oxidative stress in the intestine after injection or zymosan, an important role of oxygen radicals in the observed effects is not likely. However, in a previous study we found that hydrogen peroxide was also unable to induce lipid peroxidation in intestinal tissue,'9 implying that oxidant production by peritoneal macrophages does not itself induce lipid peroxidation processes in the intestine. Inflammatory cells release a variety of other mediators upon stimulation, which could also be directly responsible for decreased receptor responses in the surrounding tissue. 34 The results in this study show that treatment of rats with zymosan for 72 hours induces a peritoneal but not an intestinal inflammation. The intestinal longitudinal smooth muscular j3 adrenoceptor function is decreased by this treatment, which is probably not caused by oxidative stress but may due to the release of other mediators by activated peritoneal macrophages. Decreased intestinal smooth muscle receptor responses, as observed after an intraperitoneal inflammation, may also be responsible for the observed motility changes observed in intestinal inflammatory disorders.
